Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Rabuka
AddedFeb 16, 2024
UpdatedMay 31, 2026
David Rabuka

David Rabuka

Co-Founder, Acrigen Biosciences

CrunchbaseLinkedInThe Org

David Rabuka's Career

Acrigen Biosciences
Acrigen Biosciences

Alameda, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Rabuka's Career

Acrigen Biosciences
Acrigen Biosciences
Pre-Seed$1.2M112019Alameda, CA, US
Co-Founder

Leadership at Acrigen Biosciences

Heath LukatchHeath LukatchBoard Member
Joe Bondy-DenomyJoe Bondy-DenomyCo-Founder

Similar to Acrigen Biosciences

Editas MedicineEditas MedicineCambridge, MA, USGene Editing, Therapiesest. 2013Editas MedicineCambridge, MA, US · est. 2013

Editas Medicine, Inc.: A clinical-stage biotech firm pioneering CRISPR-based therapies for rare diseases.

Public · $931.6M226
MetagenomiMetagenomiEmeryville, CA, USGene Editingest. 2016MetagenomiEmeryville, CA, US · est. 2016

Metagenomi: Pioneering next-gen gene-editing systems to treat genetic diseases.

Series B · $457M191
Amber BioAmber BioSan Francisco, CA, USGene Editingest. 2021Amber BioSan Francisco, CA, US · est. 2021

Amber Bio, a San Francisco-based biotech firm, pioneers gene editing to reach untapped patient groups.

Seed · $26M2
GenEditGenEditSouth San Francisco, CA, USTherapeutic Deliveryest. 2016GenEditSouth San Francisco, CA, US · est. 2016

GenEdit Inc., a biotech firm in California, innovates CRISPR-based therapeutic delivery systems.

Series A · $67.7M47

David Rabuka's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoHong Eun-taekHong Eun-taekCEO · Kakao

People Similar to David Rabuka

Santhosh PalaniSanthosh PalaniBoard Member · Caribou BiosciencesDavid MeadDavid MeadFounder · Varigen BiosciencesDon DavidsonDon DavidsonCo-Founder · Creative BioTherapeuticsDrew TaylorDrew TaylorCo-Founder & CEO · Acorn BiolabsJohn WeissJohn WeissCEO · Acreto